VXRT Chart
See on advanced chart >
About
Vaxart, Inc. is a clinical-stage company focused on developing oral recombinant protein vaccines based on its proprietary oral vaccine platform and direct-acting antivirals to treat infections that have limited therapeutic options. Vaxart's oral vaccines are...
Read More
- HighlightA biotech company developing oral vaccines for infectious diseases and cancer
- ExchangeNASDAQ
- Listing Date12/11/1981
- Established DateInvalid Date
- Full-time Employees109
- Address170 Harbor Way Suite 300 South San Francisco California 94080
- Tel1-650-5503500
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology